Jankevičius F - Search Results

1

Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.

Daniūnaitė K, Berezniakovas A, Jankevičius F, Laurinavičius A, Lazutka JR, Jarmalaitė S. Daniūnaitė K, et al. Among authors: jankevicius f. Medicina (Kaunas). 2011;47(3):147-53. Medicina (Kaunas). 2011. PMID: 21822036 Free article. English, Lithuanian.

2

[Prostatic biopsy technique. Historical review].

Sruogis A, Jankevicius F, Mickys U. Sruogis A, et al. Among authors: jankevicius f. Medicina (Kaunas). 2005;41(11):957-67. Medicina (Kaunas). 2005. PMID: 16333219 Free article. Lithuanian.

3

[Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].

Baranauskas Z, Valuckas K, Aleknavicius E, Jankevicius F, Burneckis A, Paviloniene I. Baranauskas Z, et al. Among authors: jankevicius f. Medicina (Kaunas). 2006;42(1):11-4. Medicina (Kaunas). 2006. PMID: 16467608 Free article. Review. Lithuanian.

4

[Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer].

Asadauskiene J, Aleknavicius E, Zelviene TP, Jankevicius F. Asadauskiene J, et al. Among authors: jankevicius f. Medicina (Kaunas). 2006;42(10):781-7. Medicina (Kaunas). 2006. PMID: 17090976 Free article. Review. Lithuanian.

5

Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.

Jarmalaite S, Jankevicius F, Kurgonaite K, Suziedelis K, Mutanen P, Husgafvel-Pursiainen K. Jarmalaite S, et al. Among authors: jankevicius f. Oncology. 2008;75(3-4):145-51. doi: 10.1159/000158665. Epub 2008 Sep 29. Oncology. 2008. PMID: 18824877

6

Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study.

Jarmalaite S, Andrekute R, Scesnaite A, Suziedelis K, Husgafvel-Pursiainen K, Jankevicius F. Jarmalaite S, et al. Among authors: jankevicius f. J Cancer Res Clin Oncol. 2010 Jun;136(6):847-54. doi: 10.1007/s00432-009-0725-y. Epub 2009 Nov 19. J Cancer Res Clin Oncol. 2010. PMID: 19924441 Clinical Trial.

7

The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer.

Asadauskiene J, Aleknavicius E, Pipiriene-Zelviene T, Jankevicius F. Asadauskiene J, et al. Among authors: jankevicius f. Medicina (Kaunas). 2010;46(5):305-14. Medicina (Kaunas). 2010. PMID: 20679745 Free article.

8

Infrared spectroscopic imaging of renal tumor tissue.

Sablinskas V, Urboniene V, Ceponkus J, Laurinavicius A, Dasevicius D, Jankevicius F, Hendrixson V, Koch E, Steiner G. Sablinskas V, et al. Among authors: jankevicius f. J Biomed Opt. 2011 Sep;16(9):096006. doi: 10.1117/1.3622292. J Biomed Opt. 2011. PMID: 21950920 Free article.

9

Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer.

Sabaliauskaite R, Jarmalaite S, Petroska D, Dasevicius D, Laurinavicius A, Jankevicius F, Lazutka JR. Sabaliauskaite R, et al. Among authors: jankevicius f. Genes Chromosomes Cancer. 2012 Aug;51(8):781-91. doi: 10.1002/gcc.21963. Epub 2012 Apr 16. Genes Chromosomes Cancer. 2012. PMID: 22505341

10

Epigenetic markers of prostate cancer in plasma circulating DNA.

Cortese R, Kwan A, Lalonde E, Bryzgunova O, Bondar A, Wu Y, Gordevicius J, Park M, Oh G, Kaminsky Z, Tverkuviene J, Laurinavicius A, Jankevicius F, Sendorek DH, Haider S, Wang SC, Jarmalaite S, Laktionov P, Boutros PC, Petronis A. Cortese R, et al. Among authors: jankevicius f. Hum Mol Genet. 2012 Aug 15;21(16):3619-31. doi: 10.1093/hmg/dds192. Epub 2012 May 22. Hum Mol Genet. 2012. PMID: 22619380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page